146
Aurora Pop-Vicas et al
Table 2. Incidence of Surgical Site Infection (SSI) by Antimicrobial Prophylaxis Regimen and Randomized Controlled Trial of Women Undergoing Abdominal or Vaginal Hysterectomy
Study
Baldoni et al, 198917 Abdominal Vaginal Total
Chongsomchai et al, 200236 Abdominal
Cormio et al, 200320 Abdominal
Grossman et al, 197921 Abdominal Vaginal Total
Hemsell et al, 198437 Vaginal
Hemsell et al, 198538 Abdominal Vaginal Total
Hemsell et al, 198739 Vaginal
Cefazolin SSI / N
Cefazolin 5/25 0/10 5/35
Cefazolin 7/110
Cefazolin 2/352
Cefazolin 9/79 1/28
10/107
Cefazolin 2/63
Cefazolin 4/54 1/60
5/114
Cefazolin 1 g 3/53
Cefazolin 2 g 2/53
Hemsell et al, 199522 Abdominal
Jyothi et al, 201024 Abdominal and vaginal Periti et al, 198818 Abdominal Vaginal Total
Periti et al, 198819 Abdominal Vaginal Total
Phoolcharoen et al, 201225 Abdominal
Stiver et al, 199023 Vaginal
Note. CI, confidence interval.
Cefazolin 30/258
Cefazolin 1/24
Cefazolin 2/124 1/43
3/167
Cefazolin 13/139 5/74
18/213
Cefazolin 6/160
Cefazolin 0/73
Comparator SSI / N
Cefotetan 3/26 0/14 3/40
Ampicillin 11/110
Amoxicillin-clavulanate 2/346
Penicillin G 4/76 2/26
6/102
Ceftriaxone 1/64
Ceftriaxone 4/54 1/57
5/111
Cefoxitin 2/51
Cefotaxime 3/55
Cefotetan 15/253
Amoxicillin-clavulanate 2/36
Cefotetan 4/116 0/35
4/151
Cefotaxime 9/138 1/64
10/202
Ceftriaxone 12/160
Ceftriaxone 2/65
0.48 (0.18–1.31) .17 (0.01–3.67) .61 .15 1.77 (0.79–3.94) .16 1.96 (1.08–3.56) 0.75 (0.07–7.82) 0.67 (0.15–3.01) .03 .81 .16
1.44 (0.25–8.28) 0.69 (0.12–3.97)
.68 .68
2.03 (0.19–21.85) 0.97 (0.29–3.27) .56 .97
Risk Ratio (95% CI)
1.91 (0.49–7.40)
P Value .35
0.64 (0.26–1.58) 0.98 (0.14–6.94) 1.56 (0.59–4.21)
.33 .99 .35
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156